Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat...

Area of Science:

• Endocrinology
• Oncology
• Toxicology

Background:

• Endogenous estrogens are implicated in breast cancer development.
• Estrogen-like chemicals, such as octylphenol (OP) and genistein (GEN), warrant investigation for their effects on mammary carcinogenesis.
• Prepubertal exposure to estradiol and genistein has been linked to BRCA1 mRNA upregulation and reduced future breast cancer risk.

Purpose of the Study:

• To investigate the effects of prepubertal high-dose octylphenol (OP) and genistein (GEN) exposure on mammary carcinogenesis.
• To examine the association between OP/GEN exposure and the expression of BRCA1 and ERalpha in mammary tumors.

Main Methods:

• Prepubertal female Sprague-Dawley rats were administered daily doses of 20, 40, or 80 mg/kg OP from postnatal day 22 to 28.
• Mammary tumors were induced by a single dose of 100 mg/kg 7,12-dimethylbenz [a] anthracene (DMBA) on postnatal day 42.
• BRCA1 and ERalpha expression levels were analyzed in mammary tumors.

Main Results:

• A significant decrease in the incidence of DMBA-induced mammary tumors was observed in rats treated with 40 mg/kg OP.
• Octylphenol (OP) exposure at 40 mg/kg led to the upregulation of BRCA1 mRNA and protein expression.
• Downregulation of ERalpha expression was observed in mammary tumors of rats exposed to 40 mg/kg OP.

Conclusions:

• Exposure to 40 mg/kg octylphenol (OP) can reduce the risk of developing breast cancer later in life in prepubertal Sprague-Dawley rats.
• The protective effect of OP against mammary carcinogenesis is associated with sustained upregulation of BRCA1 and downregulation of ERalpha in the mammary tumor.
• These findings highlight a potential protective role for specific estrogen-like chemicals during critical developmental windows.